Top pharma blogs Secrets
January 21, 2025 In 21 CFR 211.94 it's mentioned that “Drug product containers and closures shall not be reactive, additive, or absorptive to alter the security, identification, power, good quality or purity with the drug beyond the Formal or established demands.” Even though the code makes this assertion, and when expanded on within the connec